World Class Speakers

 

BIOSIMILAR SPEAKERS

 

Jenny Alltoft, Global Biosimilars Lead, Pfizer, Inc. Jenny Alltoft
Global Biosimilars Lead
Pfizer, Inc.

Martin Schiestl, Chief Science Officer, Sandoz Biopharmaceuticals Martin Schiestl
Chief Science Officer
Sandoz Biopharmaceuticals

Sarfaraz K. Niazi, Chairman, Professor, Karyo Biologics/University of Illinois Sarfaraz K. Niazi
Chairman, Professor
Karyo Biologics/ University of Illinois

Marjorie A. Shapiro, Chief, Laboratory of Molecular and Developmental Immunology, Division of Biotechnology Products Research and Review I, OBP/OPQ/CDER/FDA Marjorie A. Shapiro
Chief, Laboratory of Molecular and Developmental Immunology, Division of Biotechnology Products Research and Review I
OBP/OPQ/CDER/FDA

Margaret (Maggie) Dolan, Global Head of Market Access, Biogen’s Biosimilars, Biogen Margaret Dolan
Global Head of Market Access, Biogen’s Biosimilars
Biogen

James Kent, Regional medicine procurement specialist East of England, NHS England James Kent
Regional medicine procurement specialist East of England
NHS England

Erin Federman, VP, Head of Biologics, Mylan Erin Federman
VP, Head of Biologics
Mylan

Clare Jacklin, Director of External Affairs, National Rheumatoid Arthritis Society NRAS Clare Jacklin
Director of External Affairs
National Rheumatoid Arthritis Society NRAS

Delphine F. Courmier, Health Economics Director- Biosimilars, Amgen Delphine F. Courmier
Health Economics Director- Biosimilars
Amgen

Ian Henshaw, Global Head of Biogen’s Biosimilars Unit, Biogen Ian Henshaw
Global Head of Biogen’s Biosimilars Unit
Biogen

 

The 2018 agenda will feature 300+ speakers across multiple streams and co-located events.

Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.

 

ALL 2018 SPEAKERS

 

Vladka ?Urin ?Erbec, Head, Blood Transfusion Centre of Slovenia

Marc Abromovitz, Head, Industrial Hygiene, Novartis

Marc Abromovitz at World Biosimilar Congress

Jenny Alltoft, Head of Global Biosimilars, Pfizer

Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc

Martin Axon, Principal, Occupational Hygienist of Operations for Europe, Safebridge

Martin Axon at World Biosimilar Congress

Dani Bach, Director, Healthcare Ventures, Touchstone Ventures

Dani Bach at World Biosimilar Congress

Jonathan Back, Deputy Director, Project Team Lead, Drug Discovery, Glenmark Pharmaceuticals SA

Jonathan Back at World Biosimilar Congress

Calise Bahou, PhD Student, University College London

Fabio Baschiera, Functional Head Of Clinical Development, Oncology And Hematology, Novartis

Fabio Baschiera at World Biosimilar Congress

Kevin Bateman, Distinguished Scientist, Merck Sharp & Dohme

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Karoline Bechtold Peters, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis

Karoline Bechtold Peters at World Biosimilar Congress

Dr Alain Beck, Senior Director, Analytical Chemistry, NBEs, Centre d'Immunologie Pierre Fabre

Roger Beerli, CSO, NBE Therapeutics

Roger Beerli at World Biosimilar Congress

Stephen Beers, Associate Professor, University Of Southampton

Mehdi Benchoufi, Professor, Hopitaux Universitaires Paris Centre

Krzysztof Bielikowicz, Principal Scientist, Analytical Development, Glenmark Pharma

Marc Bisschops, Director SLS, Pall Biotech

Leigh-Anne Blair, Senior Director - Clinical Operations, Onconova Therapeutics Inc

Leigh-Anne Blair at World Biosimilar Congress

Phil Bland-Ward, Chief Scientific Officer, Crescendo Biologics Ltd

Phil Bland-Ward at World Biosimilar Congress

Jonathan Bones, Principal Investigator, NIBRT

Jonathan Bones at World Biosimilar Congress

Dr Ezio Bonvini, CSO, Macrogenics

Louis Boon, Chief Scientific Officer, Bioceros

Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe GmbH

Ingrid Bourges, Clinical Assessor, Federal Agency for Medicines and Health Products

Ingrid Bourges at World Biosimilar Congress

Frank Brennan, Head of Non-Clinical Toxicology and PK/PD (Immunology), UCB Pharma

Alessandro Brigo, Principal Scientist in Pharma Research and Early Development and Toxicology Project Leader, Roche Pharmaceuticals

Alessandro Brigo at World Biosimilar Congress

Dr Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche

Jack Brown, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals Inc

Jack Brown at World Biosimilar Congress

Johannes Brozy, Senior Associate Scientist, BiTE Technology, Amgen Inc

Sebastian Bunk, Research Director, Immunology, Immatics Biotechnologies GmbH

Patrick Burke, Associate Director, Seattle Genetics Inc

Alessandro Butte, Lecturer, E.T.H. Zurich

Alessandro Butte at World Biosimilar Congress

Stefano Butti, Head of Sales Group, F.P.S. Food and Pharma Systems Srl

Stefano Butti at World Biosimilar Congress

Martina Canestraro, Senior Scientist Cell Biology, Immunocore Ltd

Paul Carter, Senior Director and Staff Scientist, Antibody Engineering, Genentech

Sarah Carter, Executive Director, Head of Global Study Operations, Amgen

Kieran Casey, Business Development Manager, Services, Bioreclamation IVT

Tim Cave, VP-Head Strategic Planning and Digital Practices, Global Medical Affairs, GSK

Tim Cave at World Biosimilar Congress

Divya Chadha Manek, Head of Business Development (Commercial), National Institute for Health Research (NIHR)

Brian Champion, CSO, Psioxus Therapeutics Ltd

Deborah Charych, Executive Director, Nektar Therapeutics

Deborah Charych at World Biosimilar Congress

Andre Choo, Principal Scientist and Director, Antibody Discovery, Bioprocessing Technology Institute

Andre Choo at World Biosimilar Congress

Mimi Choon-Quinones, Executive Senior Director, Clinical Operations and Patient Advocacy, Arena Pharmaceuticals

Dr Andre Choulika, Chairman & Chief Executive Officer, Cellectis

Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury at World Biosimilar Congress

Vijay Chudasama, Reader, UCL

Daniela Cipolletta, Investigator III, Novartis

Jeannick Cizeau, Director of Research, Eleven Biotherapeutics

Jerome Cluzeau, Senior Scientist, Lek Pharmaceutical

Jerome Cluzeau at World Biosimilar Congress

Nathalie Corvaïa, Managing Director, Institut De Recherche Pierre Fabre

Nathalie Corvaïa at World Biosimilar Congress

Anthony Costello, Vice President Of Mobile Health, Medidata Solution

Delphine Courmier, Health Economics Director, Biosimilars, Amgen Inc

Thomas Cragnolini, Senior Manager C&Q, Recombinant Facility, CSL Behring

Thomas Cragnolini at World Biosimilar Congress

Francis Crawley, Executive Director, Good Clinical Practice Alliance (GCPA)

Prentice Curry, Vice President Quality and Operations, Kite Pharma Inc

Prentice Curry at World Biosimilar Congress

Rony Dahan, Assistant Professor, Weizmann Institute of Science

Dr William Dall'Acqua, VP, R&D, MedImmune

Igor D'Angelo, Senior Scientist and Functional Lead, Amgen Inc

Lee Dawson, Senior Scientist, Molecular Pathology Group, Asterand Bioscience

Lee Dawson at World Biosimilar Congress

Emma Dean, Director, Physician And Early Phase Oncology, Astra Zeneca

Dr John Delaney, Executive Director, Amgen Biologics Discovery, Amgen

Madiha Derouazi, Chief Executive Officer, Amal Therapeutics

Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals

Richard Dicicco at World Biosimilar Congress

Dr Rakesh Dixit, Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

Rakesh Dixit, Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

Rakesh Dixit at World Biosimilar Congress

Claire Dobson, Associate Director of Antibody Discovery and Protein Engineering, MedImmune

Claire Dobson at World Biosimilar Congress

Margaret Dolan, Associate Director Market Access EU Biosimilars, Biogen

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at World Biosimilar Congress

Wendel Doubleday, Senior Director of Chemical Development, Seattle Genetics Inc

Wendel Doubleday at World Biosimilar Congress

Roman Drai, Director, Clinical Development, Geropharm

Prof Stefan Duebel, Director, Braunschweig University of Technology

Joseph Eid, Senior Vice President, Head of Global Medical Affairs, Bristol Myers Squibb

Dr Peter Ellmark, Principal Scientist, Immuno-oncology, Alligator Bioscience Ab

Peter Emtage, SVP, Global Head of Cell Therapy Research, Kite Pharma Inc

Niklas Engler, Head of Technical Development Biologics for Europe, F. Hoffmann-La Roche AG

Niklas Engler at World Biosimilar Congress

Christoph Esslinger, CSO, Memo Therapeutics

Stephan Ewert, Senior Investigator, Novartis Pharma AG

Mourad Farouk Rezk, Senior Director and Global Head of Medical Affairs, Biogen

Erin Federman, VP, Head of Biologics, Boehringer Ingelheim

Erin Federman at World Biosimilar Congress

Caroline Feys, Research & Development Operations Innovation (RDO-I) Leader, Jansen

Caroline Feys at World Biosimilar Congress

Ryan Fiehler, Principal Scientist, F-star Biotechnology Ltd

Jonny Finlay, CEO, UltraHuman

Kalveer Flora, Specialist Pharmacist Rheumatology & Biosimilars, London North West Healthcare Nhs Trust

Kalveer Flora at World Biosimilar Congress

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

Agnete Fredriksen, President and Chief Scientific Officer, Vaccibody AS

Charlotte French, Executive Director of Portfolio Relationship and Sourcing Management, Astellas Pharma

Per Ola Freskgard, Vice Director & Expert Scientist, Roche Innovation Center Basel

Aidan Fry, Editor, Generics Bulletin

Patrick Garidel, Head of Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim Pharma GmbH & Co. KG

Lothar Germeroth, Senior Vice President and Managing Director, Juno Therapeutics

Lothar Germeroth at World Biosimilar Congress

Dr David Gilham, Vice President of Research and Development, Celyad

Dr David Gilham at World Biosimilar Congress

Chris Gomez, Head of Health, Safety and Environmental, Hovione

Jorge González Borroto, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.

Jorge González Borroto at World Biosimilar Congress

Anne Goubier, Vice President Of Immunology, Tusk Therapeutics

Niels Grabe, Director, Tissue Imaging and Analysis Center, University of Heidelberg Medical Center

Niels Grabe at World Biosimilar Congress

Dr Ulf Grawunder, Chief Executive Officer & Founder, NBE Therapeutics

Sung-Hye Grieco, Senior Engineer at Early Stage Cell Culture, PTD Department, Genetech

Sung-Hye Grieco at World Biosimilar Congress

Uwe Gudat, Head of Safety, Biosimilars, Fresenius Kabi

Thomas Hach, Director Healthcare Systems, Senior Global Heath Advisor, Novartis

Eric Halioua, President and Chief Executive Officer, PDC*line pharma SA

Tina Harris, Director Data Management, Amgen Inc

Tina Harris at World Biosimilar Congress

Dr Steffen Hartmann, Global Head Integrated Biologics Profiling, Novartis

Ian Henshaw, Global Head of Biogen’s Biosimilars Unit, Biogen

Andreas Herrmann, Chief Executive Officer, Valerius Biopharma

Andreas Herrmann at World Biosimilar Congress

Matthew Hewitt, Director, Tumour Immunology & Microenvironment, Bellicum Pharmaceuticals

Stuart Hicks, Associate Director, ImmunoGen Inc

Stuart Hicks at World Biosimilar Congress

Thomas Huber, Senior Investigator, Novartis Institute for Biomedical Research

Michael Hust, Group Leader, Technical University of Braunschweig

Adama Ibrahim, Senior Clinical Operations Lead, Biogen

Simon Ittig, CEO and Co-founder, T3 Pharmaceuticals

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Ruediger Jankowsky at World Biosimilar Congress

Liping Jin, Data-Driven Recruitment Lead, F. Hoffmann-La Roche Ltd

Henk Johan Streefkerk, Medical Director, PIQUR Therapeutics

Henk Johan Streefkerk at World Biosimilar Congress

Kevin Johnson, Partner, Medicxi

Colette Johnston, Senior Director, Early Discovery, Crescendo Biologics Ltd

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology

Peter Joyce, CEO, Grey Wolf Therapeutics

Meelis Kadaja, Director of Business Development, Icosagen Cell Factory Ltd

Jan Pieter Kappelle, Senior Director Global Clinical Supplies, UCB Pharma

Ghassan Karam, Project Manager, W.H.O. I.C.T.R.P.

Dr Maria Karasarides, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals

Dr Maria Karasarides at World Biosimilar Congress

Andreas Katopodis, CEO, Anaveon

Robert Kelley, Principal Scientist, Genentech

Saad Kenderian, Assistant Professor of Medicine, Oncology, and Immunology Director, T Cell Engineering Program, Mayo Clinic

Saad Kenderian at World Biosimilar Congress

James Kent, Specialist Procurement Pharmacist London & East of England, NHS England

Houng Kim, head of the strategy and operations division, Celltrion Healthcare

Houng Kim at World Biosimilar Congress

Takashi Kei Kishimoto, Chief Science Officer, Selecta Biosciences Inc

David Klatzmann, Professor, Pierre et Marie Curie University and Medical School

David Klatzmann at World Biosimilar Congress

Roland Kontermann, Professor Of Biomedical Engineering, University of Stuttgart

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Suzette Kox, Senior Director Of International For Biosimilar Medicines Group, Medicines for Europe A.I.S.B.L.

Suzette Kox at World Biosimilar Congress

Dinesh Kundu, General Manager of Strategy, Business Development and Program Management, Intas Biopharmaceuticals

Dinesh Kundu at World Biosimilar Congress

Heinz Läubli, Attending Physician, Medical Oncology, University Hospital Basel

Andreas Hougaard Laustsen, Postdoctoral Fellow, Technical University of Denmark

Andy Lee, Senior Vice President and Head of Global Clinical Trial Operations, Merck

Disa Lee Choun, Director, Head of Data Acquisition, UCB

Disa Lee Choun at World Biosimilar Congress

Emma Lees, Senior Vice President, Research, Jounce Therapeutics

Emma Lees at World Biosimilar Congress

Jeanette Leusen, Associate Professor, Laboratory, Translational Immunology, UMC Utrecht

Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen

Zhaoyang Megan Li, Senior Director, Clinical Pharmacology, Shire

Chris Lloyd, Senior Scientist, Protein Engineering, Antibody Discovery and Protein Engineering, MedImmune U.K. Ltd

Chris Lloyd at World Biosimilar Congress

Thorsten Lorenz, Group Head of Develop ability Assessment Biologics, Novartis Pharma AG

Thorsten Lorenz at World Biosimilar Congress

Ester Lovsin Barle, Corporate Toxicologist, Lonza

Ester Lovsin Barle at World Biosimilar Congress

Juergen Lukas, Boehringer Ingelheim

Juergen Lukas at World Biosimilar Congress

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Reinhold Maeck, Head of Corporation EH&S Regulatory Intelligence, Boehringer Ingelheim

Reinhold Maeck at World Biosimilar Congress

Johannes Maier, Principal Scientist, Schrödinger

Mark Mamula, Professor of Medicine Rheumatology, Yale University

Julia Manzetti, PostDoc, Head of production of TILs, University Hospital Basel

Julia Manzetti at World Biosimilar Congress

Andrea Marschall, Postdoctoral Fellow, Brandeis University

Peter Marshall, Principal Technology Engineer, AstraZeneca

Peter Marshall at World Biosimilar Congress

Dr Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Dr Ivan Mascanfroni at World Biosimilar Congress

Justin Mason-Home, Director, HPAPI Services Limited

Justin Mason-Home at World Biosimilar Congress

Krzysztof Masternak, Head of Biology, NovImmune Sa

Ivana Matic, Global Operations Lead- Agreements, MSD

Robert Meadowcroft, CEO, The Muscular Dystrophy U.K.

Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan

Victor Lino Mendonça at World Biosimilar Congress

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Derek Michael Mason, PhD Candidate, E.T.H. Zurich

Enkelejda Miho, Professor of Digital Life Science Sciences, University of Applied Sciences and Arts Northwestern Switzerland F.H.N.W.

Ali Mohamed, VP CMC, Immatics Inc

Vera Molkenthin, Chief Scientist, Abcheck s.r.o.

Dr M. Anthony Moody, Associate Professor of Paediatrics, Assistant Professor of Immunology, Duke University Medical Center

Hans Martin Mueller, Director, BioProcess Development, MSD

Sascha Mundstein, Senior Technologist, Pfizer

Stephen Nabarro, Head of Clinical Operations and Data Management, Centre for Drug Development, Cancer Research UK

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Mariann Neverovitch, Research Scientist, Bristol Myers Squibb

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Cecil Nick, Vice President, PAREXEL

Dr Ahuva Nissim, Reader, William Harvey Research Institute

Thomas Nittoli, Director, Regeneron Pharmaceuticals

Franz-Josef Obermair, CEO and Co-founder, Tepthera

Kate O'Brien, Former Senior Research Nurse, Independent Consultant

Jennifer O'Callaghan, Clinical Data Sharing Manager, Wellcome Trust

Jennifer O'Callaghan at World Biosimilar Congress

Christian Ohmann, Chair of the Network Committee, E.C.R.I.N.

Benjamí Oller-Salvia, EMBO postdoctoral fellow, M.R.C. Laboratory of Molecular Biology

Dr Shane Olwill, Vice President of Development, Pieris Pharmaceuticals

Ber Oomen, Executive Secretary and Treasurer, ‎European Specialist Nurses Organisations

Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG

Eren Ozcagli, Academician, Istanbul University

Serafino Pantano, Director, Biomarker & Diagnostics Leader, Merck Sharp & Dohme

Jeff Parry, Senior Scientist Manufacturability, AstraZeneca

Francesco Patalano, Head Of Center Of Excellence Patient Reported Outcomes, Novartis

Pinal Patel, Strategic Recruitment Lead, Bristol Myers Squibb

Nora Pencheva, Lead Scientist, Humax-AXL-ADC Program, Genmab

Nicole Piche-Nicholas, Principal Scientist, BioMedicine Design, Pfizer

Prof. Andreas Plueckthun, Professor of Biochemistry, Director, Department of Biochemistry, University of Zurich, Dept. of Biochemistry

Mayo Pujols, VP Global CAR-T Operations & Technology, Celgene

Mayo Pujols at World Biosimilar Congress

Abhinandan Raghavan, Data Scientist, Technology and Functional Leader, Informatics, Novartis Pharma AG

Dr Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Ulrich Rant, Chief Executive Officer, Dynamic Biosensors

Ulrich Rant at World Biosimilar Congress

Dr Fabian Richter, Post-Doctoral Fellow, University of Stuttgart

Theo Rispens, Group Leader, Sanquin

Christoph Roesli, Senior Fellow, Global Drug Development, Novartis Pharma AG

Dr Stacie Ropka, Partner, Axinn

Karsten Roth, Director Clinical Operations, Cinfa Biotech

Nigel Saunders, SME Containment, GSK

Nigel Saunders at World Biosimilar Congress

Martin Schiestl, Chief Science Officer, Sandoz Novartis

Ulrich Scholz, Head of Scale Up and Processing, Bayer

Ulrich Scholz at World Biosimilar Congress

Andreas Schreiner, Director of Validation, Manufacturing Science and Technology, Novartis Ag

Andreas Schreiner at World Biosimilar Congress

Ingrid Schwarzenberger, Head of Global Regulatory Affairs Biopharmaceuticals, Sandoz Biopharmaceuticals Gmbh

Nabila Seddiki, Senior Lecturer, Paris-Est Créteil University

Peter Senter, Vice President of Chemistry, Seattle Genetics Inc

Dr Marjorie Shapiro, Supervisory Biologist Office of Biotechnology Products, CDER, FDA

Yossi Shapiro, SME - Teva Global Engineering, Teva

Yossi Shapiro at World Biosimilar Congress

Dr Marjorie Shapiro, Supervisory Biologist Office of Biotechnology Products, CDER, FDA

Whitney Shatz, Senior Scientific Researcher, Genentech

Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc

Jonathan Sheffield, Chief Executive Officer, National Institute for Health Research (NIHR)

Darko Skegro, Senior Investigator, Biotherapeutic Technologies, Novartis Institutes for Biomedical Research

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Anette Sommer, Principal Scientist, Oncology II, Bayer

Anette Sommer at World Biosimilar Congress

Shantreddy Soogareddy, Associate Director - External Development R&D (Alliance and Project management), Dr. Reddy's Laboratories Limited

Anke Steinmetz, Senior Scientist, Integrated Drug Discovery/Structure, Design & Informatics, Sanofi

Pawel Stocki, Senior Principal Scientist, Ossianix, Inc.

Dr Michael Streit, Sr Director Clinical Research Lead, Janssen

Cian Stutz, Principal Scientist, Antibody Engineering, Glenmark Pharmaceuticals

Mats Sundgren, Director, Health Informatics, AstraZeneca

Mats Sundgren at World Biosimilar Congress

Anna Tafuri, Medical Director, Translational Medicine Oncology, Bayer HealthCare

Anna Tafuri at World Biosimilar Congress

Lioudmila Tchistiakova, Senior Director of Global Biotherapeutic Technologies, Pfizer

Thomas Thoma, Head Clinical Trials Supply, Teva Pharmaceuticals

Greg Thurber, Assistant Professor of Chemical Engineering, University of Michigan

Pascal Touchon, Senior Vice President and Global Head Cell & Gene, Novartis

Pascal Touchon at World Biosimilar Congress

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Immutep Ltd

Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina

Gianluca Trifirò at World Biosimilar Congress

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill at World Biosimilar Congress

Thomas Valerius, Assistant Professor, Section for Stem Cell Transplantation and Immunotherapy, University Of Kiel

Maarten Van Baelen, Market Access Director, Medicines for Europe

Maarten Van Baelen at World Biosimilar Congress

Vivienne Van De Walle, Medical Director, PT&R

Peter Van Der Ark, Clinical Scientist, Janssen Pharmaceutical

Bernard Vanhove, Chief Operating Officer, Director of R&D and International Scientific Collaborations, O.S.E. Immunotherapeutics

Laszlo Vasko, Senior Director, Business Technology Leader - Clinical Operations and Innovation, Janssen Pharmaceutical

Wouter Verdurmen, Assistant Professor, Radboud University Medical Center

Dr Alain Vertes, Vice President, Alliance Manageement, NxR Biotechnologies

Alain Vertes, Managing Director, NxR Biotechnologies

Alain Vertes at World Biosimilar Congress

Meenu Wadhwa, Section Leader for Cyotkines and Growth Factors Section, NIBSC

Meenu Wadhwa at World Biosimilar Congress

Dr Carl Webster, Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune Cambridge

Moritz Wolf, Research Scientist, E.T.H. Zurich

Dr Jens Würthner, Head of Clinical Development – EU, ADC Therapeutics

Mingjie Xie, Chief Executive Officer, Rapid Novor

Wei Xu, Principal Scientist, Analytical Method Development, Merck Research Laboratories

Tianbo Xu, UCL

Yang Yang, Senior Scientist, Novartis

Baolin Zhang, Senior Investigator and Review Team Leader, F.D.A. C.D.E.R.

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc

Ildiko Ziegler at World Biosimilar Congress

 

 

 

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates